Relay Therapeutics’ $63 million Round Funding

Goodwin advised Relay Therapeutics on the deal Proceeds from the financing will be used to advance Relay Therapeutics’ pipeline of oncology candidate medicines as they progress…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here